These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2201981)

  • 1. DNA adduct formation in relation to tumorigenesis in mice continuously administered 4-aminobiphenyl.
    Beland FA; Fullerton NF; Marques MM; Melchior WB; Smith BA; Poirier MC
    Prog Clin Biol Res; 1990; 340A():81-90. PubMed ID: 2201981
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA adduct formation in relation to tumorigenesis in mice chronically fed 2-acetylaminofluorene.
    Beland FA; Fullerton NF; Kinouchi T; Smith BA; Poirier MC
    Prog Clin Biol Res; 1990; 331():121-9; discussion 147-8. PubMed ID: 2315340
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA adduct formation and aromatic amine tumorigenesis.
    Beland FA; Fullerton NF; Smith BA; Poirier MC
    Prog Clin Biol Res; 1992; 374():79-92. PubMed ID: 1620719
    [No Abstract]   [Full Text] [Related]  

  • 4. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
    Yoon JI; Kim SI; Tommasi S; Besaratinia A
    Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels.
    Poirier MC; Fullerton NF; Smith BA; Beland FA
    Carcinogenesis; 1995 Dec; 16(12):2917-21. PubMed ID: 8603464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents.
    Poirier MC; Beland FA
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):161-5. PubMed ID: 7889840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A probe for the mutagenic activity of the carcinogen 4-aminobiphenyl: synthesis and characterization of an M13mp10 genome containing the major carcinogen-DNA adduct at a unique site.
    Lasko DD; Basu AK; Kadlubar FF; Evans FE; Lay JO; Essigmann JM
    Biochemistry; 1987 Jun; 26(11):3072-81. PubMed ID: 3300770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct formation during continuous feeding of 2-acetylaminofluorene at multiple concentrations.
    Beland FA; Fullerton NF; Kinouchi T; Poirier MC
    IARC Sci Publ; 1988; (89):175-80. PubMed ID: 3198200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl.
    Jiang W; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1999 May; 156(3):187-94. PubMed ID: 10222311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenesis of 4-aminobiphenyl in BALB/cStCrlfC3Hf/Nctr mice.
    Schieferstein GJ; Littlefield NA; Gaylor DW; Sheldon WG; Burger GT
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):865-73. PubMed ID: 2995043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors.
    Cohen SM; Ellwein LB
    Toxicol Pathol; 1995; 23(2):136-42. PubMed ID: 7569667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice.
    Li Y; Chen Z; Paonessa JD; Meinl W; Bhattacharya A; Glatt H; Vouros P; Zhang Y
    Cancer Med; 2018 Nov; 7(11):5604-5610. PubMed ID: 30306738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of 3,2'-dimethyl-4-aminobiphenyl DNA adduct formation in various organs of Syrian golden hamsters.
    Yaono M; Hasegawa R; Kato K; Kimura J; Lin C; Tada M; Shirai T
    Cancer Lett; 1996 Jan; 98(2):145-9. PubMed ID: 8556701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal N-hydroxylase modification as a first step in carcinogenesis by arylamines [proceedings].
    Roberfroid M; Razzouk C; Mercier M
    Arch Int Physiol Biochim; 1977 Apr; 85(2):429-31. PubMed ID: 71125
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of continued versus discontinued administration of 2-acetylaminofluorene on the morphology and behavior of hepatocellular and urinary bladder tumors in mice.
    Frith CH; Kodell RL; Farmer JH
    J Environ Pathol Toxicol Oncol; 1986; 7(1-2):17-23. PubMed ID: 3795011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
    Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A COMPARISON OF THE PATHOLOGICAL EFFECTS OF 2-ACETYLAMINOFLUORENE, 4-ACETYLAMINOBIPHENYL, AND 2-ACETYLAMINOBIPHENYL IN THE DOG.
    JABARA AG
    Cancer Res; 1963 Jul; 23():921-7. PubMed ID: 14079158
    [No Abstract]   [Full Text] [Related]  

  • 20. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.